|
WO2008124842A1
|
|
Treatments with helminths
|
|
WO2007103543A2
|
|
The role of the mk2 pathway in wound repair
|
|
WO2007061936A2
|
|
Clearance of abnormal iga1 in iga1 deposition diseases
|
|
CA2629283A1
|
|
Methods for preparing cord matrix stem cells (cmsc) for long term storage and for preparing a segment of umbilical cord for cryopreservation
|
|
WO2007041439A2
|
|
Centrosomal proteins, nucleic acids and method of use thereof
|
|
WO2007030706A1
|
|
Fragments of the glucagon-like peptide-i and uses thereof
|
|
WO2007028117A2
|
|
P8 as a marker for heart failure
|
|
WO2007028155A2
|
|
Fragment size distribution pattern of amniotic fluid cell-free fetal dna for prenatal diagnosis
|
|
WO2007005595A1
|
|
Pregnancy-associated progenitor cells
|
|
WO2006124630A2
|
|
Compositions and methods for enhancing the efficacy of vaccines
|
|
WO2006113728A2
|
|
Inhibiting biofilm formation
|
|
US2006099630A1
|
|
NES-1 polypeptides, DNA, and related molecules and methods
|
|
US2006252684A1
|
|
Osteopontin-based cancer therapies
|
|
CA2586344A1
|
|
G protein coupled receptor agonists and antagonists and methods of use
|
|
WO2006031544A2
|
|
Methods for detection of pathogens in red blood cells
|
|
CA2566133A1
|
|
Chest wall protector
|
|
US2007110710A1
|
|
Treatment with immunoregulatory t cells
|
|
WO2004103310A2
|
|
Methods and compositions for the treatment of metabolic disorders
|
|
US2004267153A1
|
|
Detecting ischemia
|
|
EP1603511A2
|
|
Treatment of igai deposition diseases
|
